Department of Chemical and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Biotechnol J. 2013 Sep;8(9):985-96. doi: 10.1002/biot.201200275. Epub 2013 Apr 24.
Altered metabolism is linked to the appearance of various human diseases and a better understanding of disease-associated metabolic changes may lead to the identification of novel prognostic biomarkers and the development of new therapies. Genome-scale metabolic models (GEMs) have been employed for studying human metabolism in a systematic manner, as well as for understanding complex human diseases. In the past decade, such metabolic models - one of the fundamental aspects of systems biology - have started contributing to the understanding of the mechanistic relationship between genotype and phenotype. In this review, we focus on the construction of the Human Metabolic Reaction database, the generation of healthy cell type- and cancer-specific GEMs using different procedures, and the potential applications of these developments in the study of human metabolism and in the identification of metabolic changes associated with various disorders. We further examine how in silico genome-scale reconstructions can be employed to simulate metabolic flux distributions and how high-throughput omics data can be analyzed in a context-dependent fashion. Insights yielded from this mechanistic modeling approach can be used for identifying new therapeutic agents and drug targets as well as for the discovery of novel biomarkers. Finally, recent advancements in genome-scale modeling and the future challenge of developing a model of whole-body metabolism are presented. The emergent contribution of GEMs to personalized and translational medicine is also discussed.
代谢改变与多种人类疾病的发生有关,深入了解与疾病相关的代谢变化可能有助于发现新的预后生物标志物并开发新的治疗方法。基于基因组规模的代谢模型(GEM)已被用于系统研究人类代谢,以及用于理解复杂的人类疾病。在过去十年中,这种代谢模型作为系统生物学的一个基本方面,开始有助于理解基因型和表型之间的机制关系。在这篇综述中,我们重点介绍了人类代谢反应数据库的构建,使用不同程序生成健康细胞类型和癌症特异性 GEM,以及这些发展在人类代谢研究和鉴定与各种疾病相关的代谢变化中的潜在应用。我们进一步研究了如何在计算机中使用基因组规模的重建来模拟代谢通量分布,以及如何以依赖上下文的方式分析高通量组学数据。从这种基于机制的建模方法中获得的见解可用于鉴定新的治疗剂和药物靶点,以及发现新的生物标志物。最后,介绍了基因组规模建模的最新进展以及开发全身代谢模型的未来挑战。还讨论了 GEM 在个性化和转化医学中的新兴贡献。